Related Experiment Video
Updated: Aug 8, 2026

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
Published on: July 10, 2014
Histoplasmosis in Indianapolis
1Indiana University School of Medicine, Richard L. Roudebush Veterans Administration Hospital, Indianapolis.
Abstract:
Recurrent outbreaks of histoplasmosis in Indianapolis since 1978 have expanded our understanding of histoplasmosis. Histoplasmosis has emerged as the leading opportunistic infection in patients with AIDS from Indianapolis. Clinical manifestations of histoplasmosis are influenced by host factors. Underlying lung disease predisposes to chronic pulmonary histoplasmosis, and immunosuppressive medications or disorders predispose to dissemination. Inflammatory manifestations, including arthritis, erythema nodosum, and pericarditis, commonly occur with acute histoplasmosis. Diagnosis of histoplasmosis requires understanding of the accuracy and limitations of cultural and serological methods. More recently, radioimmunoassay for polysaccharide antigen has offered a new diagnostic approach. Amphotericin B remains the gold standard for treatment and is highly effective, even in immunocompromised individuals. Itraconazole shows promise as an alternative to amphotericin B for treatment of less severely ill patients. The role of fluconazole in therapy remains unknown until ongoing clinical trials are completed. Histoplasmosis cannot be cured in individuals with AIDS and in a small proportion of other individuals with other underlying immunosuppressive conditions. In such cases, long-term maintenance treatment is required to prevent relapse. Antigen detection has proven useful for following progress during treatment and for identifying relapse.
Insights
Recurrent histoplasmosis outbreaks highlight its impact on AIDS patients. Diagnosis and treatment, including Amphotericin B and Itraconazole, are crucial for managing this opportunistic infection.
Area of Science:
- Mycology
- Infectious Diseases
- Public Health
Background:
- Recurrent histoplasmosis outbreaks in Indianapolis since 1978 have significantly advanced understanding of the disease.
- Histoplasmosis is now the primary opportunistic infection among individuals with acquired immunodeficiency syndrome (AIDS) in Indianapolis.
- Host factors critically influence the clinical presentation of histoplasmosis.
Purpose of the Study:
- To review the epidemiology, clinical manifestations, diagnostic methods, and treatment strategies for histoplasmosis.
- To emphasize the challenges and management of histoplasmosis in immunocompromised populations, particularly those with AIDS.
- To discuss the evolving diagnostic landscape and therapeutic options for histoplasmosis.
Main Methods:
- Review of clinical data and epidemiological trends of histoplasmosis outbreaks.
- Analysis of diagnostic accuracy for cultural, serological, and antigen detection methods.
- Evaluation of treatment outcomes with Amphotericin B, Itraconazole, and other antifungal agents.
Main Results:
- Underlying lung disease can lead to chronic pulmonary histoplasmosis.
- Immunosuppression increases the risk of disseminated histoplasmosis.
- Inflammatory conditions like arthritis and pericarditis are common in acute histoplasmosis.
- Radioimmunoassay for polysaccharide antigen offers a novel diagnostic approach.
- Amphotericin B is highly effective, while Itraconazole shows promise for less severe cases.
- Antigen detection aids in monitoring treatment response and identifying relapses.
Conclusions:
- Histoplasmosis requires careful diagnosis considering host factors and diagnostic test limitations.
- Amphotericin B remains the standard treatment, with Itraconazole as a viable alternative for select patients.
- Long-term maintenance therapy is essential for individuals with AIDS or other immunosuppressive conditions to prevent relapse.
- Antigen detection is valuable for therapeutic monitoring and relapse detection in histoplasmosis management.
More Related Videos
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
11:28Analysis of Iophenoxic Acid Analogues in Small Indian Mongoose (Herpestes Auropunctatus) Sera for Use as an Oral Rabies Vaccination Biological Marker
Published on: May 31, 2019
Related Concept Videos
Diversity of Protists II
Rocky Mountain Spotted Fever
Toxoplasmosis
American Trypanosomiasis
Amebiasis